WallStSmart

Cryoport Inc (CYRX)vsExpeditors International of Washington, Inc. (EXPD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Expeditors International of Washington, Inc. generates 6355% more annual revenue ($12.04B vs $186.45M). EXPD leads profitability with a 7.6% profit margin vs -20.1%. EXPD appears more attractively valued with a PEG of 2.99. EXPD earns a higher WallStSmart Score of 66/100 (B-).

CYRX

Avoid

34

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 4.0Quality: 6.0
Piotroski: 4/9Altman Z: 0.39

EXPD

Strong Buy

66

out of 100

Grade: B-

Growth: 7.3Profit: 7.5Value: 3.3Quality: 8.0
Piotroski: 5/9Altman Z: 4.70
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CYRX.

EXPDSignificantly Overvalued (-62.6%)

Margin of Safety

-62.6%

Fair Value

$99.58

Current Price

$192.60

$93.02 premium

UndervaluedFair: $99.58Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CYRX1 strengths · Avg: 8.0/10
Price/BookValuation
1.8x8/10

Reasonable price relative to book value

EXPD5 strengths · Avg: 9.8/10
Return on EquityProfitability
43.4%10/10

Every $100 of equity generates 43 in profit

Revenue GrowthGrowth
32.1%10/10

Revenue surging 32.1% year-over-year

EPS GrowthGrowth
51.5%10/10

Earnings expanding 51.5% YoY

Altman Z-ScoreHealth
4.7010/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.279/10

Conservative balance sheet, low leverage

Areas to Watch

CYRX4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$787.59M3/10

Smaller company, higher risk/reward

PEG RatioValuation
62.132/10

Expensive relative to growth rate

Return on EquityProfitability
-7.4%2/10

ROE of -7.4% — below average capital efficiency

EXPD4 concerns · Avg: 3.3/10
P/E RatioValuation
27.1x4/10

Moderate valuation

Price/BookValuation
11.8x4/10

Trading at 11.8x book value

Profit MarginProfitability
7.6%3/10

7.6% margin — thin

PEG RatioValuation
2.992/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CYRX

The strongest argument for CYRX centers on Price/Book.

Bull Case : EXPD

The strongest argument for EXPD centers on Return on Equity, Revenue Growth, EPS Growth. Revenue growth of 32.1% demonstrates continued momentum.

Bear Case : CYRX

The primary concerns for CYRX are EPS Growth, Market Cap, PEG Ratio.

Bear Case : EXPD

The primary concerns for EXPD are P/E Ratio, Price/Book, Profit Margin.

Key Dynamics to Monitor

CYRX profiles as a turnaround stock while EXPD is a hypergrowth play — different risk/reward profiles.

CYRX carries more volatility with a beta of 1.90 — expect wider price swings.

EXPD is growing revenue faster at 32.1% — sustainability is the question.

EXPD generates stronger free cash flow (167M), providing more financial flexibility.

Bottom Line

EXPD scores higher overall (66/100 vs 34/100) and 32.1% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cryoport Inc

INDUSTRIALS · INTEGRATED FREIGHT & LOGISTICS · USA

Cryoport, Inc., a life sciences services company, provides temperature controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Brentwood, Tennessee.

Visit Website →

Expeditors International of Washington, Inc.

INDUSTRIALS · INTEGRATED FREIGHT & LOGISTICS · USA

Expeditors (Expeditors International of Washington) is an American worldwide logistics and freight forwarding company headquartered in Seattle, Washington.

Want to dig deeper into these stocks?